Long-form deep dives you can read and share.
A peptide drug aiming to lift the scar ‘brakes’ on regeneration and plasticity after SCI.
CONNECT Phase 1b/2a: biomarker effect; functional endpoints not significant
What it is, where it is in trials, and what we can realistically expect.